The 3-in-1 self-test is intended for the qualitative detection and differentiation of nucleocapsid protein antigens from influenza type A and type B as well as SARS-CoV-2.
The Association for Accessible Medicines submitted a formal statement for the record for the Senate Committee on the Judiciary hearing on drug pricing.